SUDARSHAN PHARMA INDUSTRIES
Back to Cashflow Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-14 Cr | ₹-12 Cr | ₹66 Cr | ₹4.26 Cr | ₹-1.49 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹-12 Cr |
| Mar2023 | ₹66 Cr |
| Mar2022 | ₹4.26 Cr |
| Mar2021 | ₹-1.49 Cr |
How is Cash Flow from Financing Activities of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹-12 Cr | Negative | |
| Mar2023 | ₹66 Cr | 1,447.24 | |
| Mar2022 | ₹4.26 Cr | Positive | |
| Mar2021 | ₹-1.49 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,053.1 Cr | 7.2% | 21.7% | 22.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 7.2% |
21.7% |
22.7% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses